RSS
News



Irish researchers discover drug that can kill leukemia cells



Bookmark and Share

Researchers from Trinity College Dublin have teamed up with colleagues from the University of Siena to discover a drug that can kill leukemia cells
Researchers from Trinity College Dublin have teamed up with colleagues from the University of Siena to discover a drug that can kill leukemia cells

Researchers from Trinity College Dublin have teamed up with colleagues from the University of Siena in Italy to discover a drug that can kill leukemia cells.

Pyrrolo-1.5-benzoxazepine-15 (PBOX-15) is capable of killing previously resistant strains of leukemia.

The Irish Cancer Society funded the research project and tests show that while the new drug kills chronic lymphocytic leukemia, it does no harm to normal blood cells.

The research findings from the Irish/Italian efforts have been published in the latest edition of “Cancer Research.”

The study’s lead investigator, Professor Mark Lawler from the School of Medicine at Trinity, paid tribute to the international effort.

“This important discovery is the result of a truly collaborative approach, involving researchers across the different disciplines of chemistry, biochemistry and molecular medicine at TCD, together with our colleagues in Siena and Belfast,” he said.

“The complimentary expertise allowed us to approach the problem of killing CLL cells from a number of angles.”

While cancerous cells can become resistant to chemotherapy, the PBOX-15 drug kills even the resistant ones by breaking them down and causing them to die.

PBOX-15 was able to kill cancerous cells that were resistant to fludarabine, which is most used to fight leukemia today.

CEO of The Irish Cancer Society, John McCormack, hailed the finding of the research.

"The Irish Cancer Society welcomes these research findings and is proud to have funded this high quality research. The Society is the largest voluntary funder of cancer research in Ireland and one of our objectives is to fund researchers that will ultimately develop new and better treatments for cancer patients” he said.
 
“The findings that are being published today emphasize the potential for basic science discoveries to translate to clinical benefit.  These findings now need to be brought from the laboratory to the bedside so that they will ultimately benefit patients with this common form of leukemia.”

Tests will continue to see if there are side effects but the news comes as a major breakthrough in the fight against leukemia.



Be the first to make a comment.

It may take several minutes for your comment to appear.


Click to learn more from DiscoverIreland.com.
IrishCentral Mobile QR code


Connect to IrishCentral with your Facebook account


or sign-in directly

Welcome to IrishCentral!
Please provide the following information in order to create your account

Username:
E-Mail Address:
Password:
Confirm Password:
I agree to the Terms of Use and Privacy Policy


Welcome to IrishCentral!
All we need is the following information and you will be part of the #1 Irish community in the US

E-Mail Address:
First select a unique username:
Username:
Now choose a password:
Password:
Confirm Password:
I agree to the Terms of Use and Privacy Policy
Thank you!

Just one more step and you will be part of the largest Irish community in America! Tell us a little more about you to start enjoying all the features of IrishCentral.

Additional Information:

First Name:
Last Name:
Date of Birth:
Zip:
Gender: Male  Female 
Country:

Degree of Irishness:
Household Income:
Level of Education:

Subscribe to our newsletters:

The Best of IrishCentral - Daily Newsletter
Special Offers from our sponsors

or
Skip

You can edit your information at any time, just go to "my account" when you're logged in.

Log into IrishCentral with your Facebook account


or sign-in directly

E-Mail:
Password:
 Remember me Forgot my password